The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Kim O.T.

National Medical Research Center for Therapy and Preventive Medicine

Dadaeva V.A.

National Medical Research Center for Therapy and Preventive Medicine;
Peoples’ Friendship University of Russia named after Patrice Lumumba

Obese patient safety: is it possible to predict the risks at all stages of medical care?

Authors:

Drapkina O.M., Kim O.T., Dadaeva V.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(3): 87‑94

DOI: 10.17116/profmed20212403187

Read: 3050 times

Download PDF (RU)
Contact the author
Table of contents

OBESE PATIENT SAFETY: IS IT POSSIBLE TO PREDICT THE RISKS AT ALL STAGES OF MEDICAL CARE?
OBESE PATIENT SAFETY: IS IT POSSIBLE TO PREDICT THE RISKS AT ALL STAGES OF MEDICAL CARE?

To cite this article:

Drapkina OM, Kim OT, Dadaeva VA. Obese patient safety: is it possible to predict the risks at all stages of medical care? Russian Journal of Preventive Medicine. 2021;24(3):87‑94. (In Russ.)
https://doi.org/10.17116/profmed20212403187

 
 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Proton pump inhi­bitors: posi­tive and nega­tive properties. On the 45th anni­versary of their discovery. Russian Journal of Preventive Medi­cine. 2024;(11):135-140
Chro­nic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medi­cine. 2025;(1):115-121
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Options for the surgical technique of lapa­roscopic sleeve gastrectomy for prevention and treatment of gastroesophageal reflux in patients with obesity. Endo­scopic Surgery. 2024;(6):57-68
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
Comparative analysis of the state of the microvasculature of the oral mucosa in persons with meta­bolic syndrome in the aspect of orthopedic dental reha­bilitation. Stomatology. 2024;(6-2):15-22
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79
Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chro­nic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60
Safety asse­ssment of bariatric surgery in the Russian Fede­ration acco­rding to the Russian National Bariatric Regi­stry. Endo­scopic Surgery. 2025;(1):5-14
Abstract:

Obese patients represent a special group of increased risk of adverse events at all stages of medical care. With obesity the post-vaccination immunity and the effectiveness of reproductive technologies decrease, the risk of morbidity and severe course of infectious diseases, side effects of drugs, complications during anesthetic and surgical procedures increase. Creation the systematic approach to the safety of an obese patient will allow anticipating and reducing the likelihood of possible adverse events.

Keywords:

obesity
adverse events
post-vaccination response
drug side effects
perioperative complications
decreased fertility

Authors:

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Kim O.T.

National Medical Research Center for Therapy and Preventive Medicine

Dadaeva V.A.

National Medical Research Center for Therapy and Preventive Medicine;
Peoples’ Friendship University of Russia named after Patrice Lumumba

Received:

14.10.2020

Accepted:

28.10.2020

Close metadata

References:

  1. World Health Organization. Noncommunicable diseases progress monitor, 2017. Geneva: WHO; 2017. Accessed January 14, 2021. https://www.who.int/nmh/publications/ncd-progress-monitor-2017/en
  2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193. 
  3. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010; 363(23):2211-2219. https://doi.org/10.1056/NEJMoa1000367
  4. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.
  5. Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715-723. PMID: 28489290. https://doi.org/10.1111/obr.12551
  6. Booth CM, Moore CE, Eddleston J, Sharman M, Atkinson D, Moore JA. Patient safety incidents associated with obesity: a review of reports to the National Patient Safety Agency and recommendations for hospital practice. Postgrad Med J. 2011;87(1032):694-699.  https://doi.org/10.1136/pgmj.2010.106989
  7. Petrini F, Di Giacinto I, Cataldo R, Esposito C, Pavoni V, Donato P, Trolio A, Merli G, Sorbello M, Pelosi P; Obesity Task Force for the SIAARTI Airway Management Study Group. Perioperative and periprocedural airway management and respiratory safety for the obese patient: 2016 SIAARTI Consensus. Minerva Anestesiol. 2016;82(12):1314-1335.
  8. Lawati MHA, Dennis S, Short SD, Abdulhadi NN. Patient safety and safety culture in primary health care: a systematic review. BMC Fam Pract. 2018;19(1):104.  https://doi.org/10.1186/s12875-018-0793-7
  9. Andersen CJ, Murphy KE, Fernandez ML. Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr. 2016;7(1):66-75.  https://doi.org/10.3945/an.115.010207
  10. Trim W, Turner JE, Thompson D. Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity. Front Immunol. 2018;9:169.  https://doi.org/10.3389/fimmu.2018.00169
  11. Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark Ed). 2019;24:890-934. 
  12. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97.  https://doi.org/10.1038/nri2921
  13. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 1985;254(22):3187-3189.
  14. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986; 314(21):1393. https://doi.org/10.1056/NEJM198605223142120
  15. Ozdemir R, Canpolat FE, Yurttutan S, Oncel MY, Erdeve O, Dilmen U. Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: a prospective randomized study. Vaccine. 2012;30(21):3155-3158. https://doi.org/10.1016/j.vaccine.2012.02.068
  16. Middleman AB, Anding R, Tung C. Effect of needle length when immunizing obese adolescents with hepatitis B vaccine. Pediatrics. 2010;125(3): 508-512.  https://doi.org/10.1542/peds.2009-1592
  17. Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422-4429. https://doi.org/10.1016/j.vaccine.2015.06.101
  18. Huang JY, Kaur BP, Seth D, et al. Can obesity alter the immune response to childhood vaccinations? Presented at: American Academy of Allergy, Asthma & Immunology Annual Meeting 2019. San Francisco, CA; 2018. https://www.pulmonologyadvisor.com/home/meetings/aaaai-2019/children-with-obesity-have-lower-immune-response-to-vaccinations
  19. Esposito S, Giavoli C, Trombetta C, Bianchini S, Montinaro V, Spada A, Montomoli E, Principi N. Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. Vaccine. 2016;34(1):56-60. 
  20. Petousis-Harris H. Vaccine injection technique and reactogenicity--evidence for practice. Vaccine. 2008;26(50):6299-6304. https://doi.org/10.1016/j.vaccine.2008.08.052
  21. Petousis-Harris H, Jackson C, Stewart J, Coster G, Turner N, Goodyear-Smith F, Lennon D. Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents. Hum Vaccin Immunother. 2015;11(7):1875-1880. https://doi.org/10.1080/21645515.2015.1016670
  22. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. BMJ. 2020;369:m1966. https://doi.org/10.1136/bmj.m1966
  23. Kass DA, Duggal P, Cingolani, O. Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020;395(10236):1544-1545. https://doi.org/10.1016/s0140-6736(20)31024-2
  24. Maccioni L, Weber S, Elgizouli M, Stoehlker AS, Geist I, Peter HH, Vach W, Nieters A. Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health. 2018;18(1):271.  https://doi.org/10.1186/s12889-018-5172-8
  25. Farnsworth CW, Schott EM, Benvie AM, Zukoski J, Kates SL, Schwarz EM, Gill SR, Zuscik MJ, Mooney RA. Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant-associated bone infection. J Orthop Res. 2018;36(6): 1614-1623. https://doi.org/10.1002/jor.238315172-8
  26. Zulkipli MS, Dahlui M, Jamil N, Peramalah D, Wai HVC, Bulgiba A, Rampal S. The association between obesity and dengue severity among pediatric patients: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018; 12(2):e0006263. https://doi.org/10.1371/journal.pntd.0006263
  27. Roth J, Sahota N, Patel P, Mehdi SF, Wiese MM, Mahboob HB, Bravo M, Eden DJ, Bashir MA, Kumar A, Alsaati F, Kurland IJ, Brima W, Danoff A, Szulc AL, Pavlov VA, Tracey KJ, Yang H. Obesity paradox, obesity orthodox, and the metabolic syndrome: An approach to unity. Mol Med. 2017; 22:873-885. 
  28. Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981-1000. https://doi.org/10.1016/j.autrev.2014.07.001
  29. Iannone F, Lopalco G, Rigante D, Orlando I, Cantarini L, Lapadula G. Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy. Autoimmun Rev. 2016;15(5):447-450.  https://doi.org/10.1016/j.autrev.2016.01.010
  30. Sheng X, Mittelman SD. The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia. Front Pediatr. 2014;2:53.  https://doi.org/10.3389/fped.2014.00053
  31. Jain R, Chung SM, Jain L, Khurana M, Lau SW, Lee JE, Vaidyanathan J, Zadezensky I, Choe S, Sahajwalla CG. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther. 2011;90(1):77-89.  https://doi.org/10.1038/clpt.2011.104
  32. Morrish GA, Pai MP, Green B. The effects of obesity on drug pharmacokinetics in humans. Expert Opin Drug Metab Toxicol. 2011;7(6):697-706.  https://doi.org/10.1517/17425255.2011.570331
  33. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH; American Society of Clinical Oncology. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30(13):1553-1561. https://doi.org/10.1200/JCO.2011.39.9436
  34. Han PY, Duffull SB, Kirkpatrick CM, Green B. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther. 2007;82(5):505-508.  https://doi.org/10.1038/sj.clpt.6100381
  35. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58(2):119-133.  https://doi.org/10.1111/j.1365-2125.2004.02157.x
  36. Janson B, Thursky K. Dosing of antibiotics in obesity. Curr Opin Infect Dis. 2012;25(6):634-649.  https://doi.org/10.1097/QCO.0b013e328359a4c1
  37. Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol. 1983;24(5):643-647.  https://doi.org/10.1007/BF00542215
  38. Barras M, Legg A. Drug dosing in obese adults. Aust Prescr. 2017;40(5):189-193.  https://doi.org/10.18773/austprescr.2017.053
  39. Neri SGR, Oliveira JS, Dario AB, Lima RM, Tiedemann A. Does obesity increase the risk and severity of falls in people aged 60 years and older? A systematic review and meta-analysis of observational studies. The Journals of Gerontology: Series A. 2020;75(5):952-960. Published: 21 November 2019. https://doi.org/10.1093/gerona/glz272
  40. Hosseini SR, Zabihi A, Jafarian Amiri SR, Bijani A. Polypharmacy among the Elderly. J Midlife Health. 2018;9(2):97-103.  https://doi.org/10.4103/jmh.JMH_87_17
  41. Hosseini SR, Cumming RG, Kheirkhah F, Nooreddini H, Baiani M, Mikaniki E, Taghipour-darzi M, Akhavan Niaki H, Rasolinejad SA, Mostafazadeh A, Parsian H, Bijani A. Cohort profile: the Amirkola Health and Ageing Project (AHAP). Int J Epidemiol. 2014;43(5):1393-400.  https://doi.org/10.1093/ije/dyt089
  42. Members of the Working Party, Nightingale CE, Margarson MP, Shearer E, Redman JW, Lucas DN, Cousins JM, Fox WT, Kennedy NJ, Venn PJ, Skues M, Gabbott D, Misra U, Pandit JJ, Popat MT, Griffiths R; Association of Anaesthetists of Great Britain; Ireland Society for Obesity and Bariatric Anaesthesia. Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia. Anaesthesia. 2015;70(7):859-876.  https://doi.org/10.1111/anae.13101
  43. Yakushiji H, Goto T, Shirasaka W, Hagiwara Y, Watase H, Okamoto H, Hasegawa K; Japanese Emergency Medicine Network investigators. Associations of obesity with tracheal intubation success on first attempt and adverse events in the emergency department: An analysis of the multicenter prospective observational study in Japan. PLoS One. 2018;13(4):e0195938. https://doi.org/10.1371/journal.pone.0195938
  44. De Jong A, Molinari N, Pouzeratte Y, Verzilli D, Chanques G, Jung B, Futier E, Perrigault PF, Colson P, Capdevila X, Jaber S. Difficult intubation in obese patients: incidence, risk factors, and complications in the operating theatre and in intensive care units. Br J Anaesth. 2015;114(2):297-306.  https://doi.org/10.1093/bja/aeu373
  45. Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med. 2016;11:28.  https://doi.org/10.1186/s40248-016-0066-z
  46. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-111.  https://doi.org/10.1161/CIRCULATIONAHA.107.189375
  47. Vreeswijk SJ, van Rutte PW, Nienhuijs SW, Bouwman RA, Smulders JF, Buise MP. The safety and efficiency of a fast-track protocol for sleeve gastrectomy: a team approach. Minerva Anestesiol. 2018;84(8):898-906.  https://doi.org/10.23736/S0375-9393.17.12298-4
  48. Wezenbeek, MR, Pouwels S, Buise M., Smulders JF., Nienhuijs S, van Montfort G. Conventional versus fast track anaesthesia in an unselected group of patients undergoing revisional bariatric surgery. International Journal of Surgery Open. 2015;1:22-27.  https://doi.org/10.1016/j.ijso.2016.02.008
  49. Goldsammler M, Merhi Z, Buyuk E. Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reprod Biol Endocrinol. 2018;16(1):45.  https://doi.org/10.1186/s12958-018-0366-6
  50. Huttunen R, Karppelin M, Syrjänen J. Obesity and nosocomial infections. Journal of Hospital Infection. 2013;85(1):8-16.  https://doi.org/10.1016/j.jhin.2013.06.012
  51. Xing D, Ma JX, Ma XL, Song DH, Wang J, Chen Y, Yang Y, Zhu SW, Ma BY, Feng R. A methodological, systematic review of evidence-based independent risk factors for surgical site infections after spinal surgery. Eur Spine J. 2013;22(3):605-615. Published: 22 September 2012. https://doi.org/10.1007/s00586-012-2514-6
  52. Wick EC, Hirose K, Shore AD, Clark JM, Gearhart SL, Efron J, Makary MA. Surgical site infections and cost in obese patients undergoing colorectal surgery. Arch Surg. 2011;146(9):1068-1072. https://doi.org/10.1001/archsurg.2011.117
  53. Bochicchio GV, Joshi M, Bochicchio K, Nehman S, Tracy JK, Scalea TM. Impact of Obesity in the Critically Ill Trauma Patient: A Prospective Study. Journal of the American College of Surgeons. 2006;203(4):533-538.  https://doi.org/10.1016/j.jamcollsurg.2006.07.001
  54. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury J-C. Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study. Critical Care Medicine. 2004;32(4):998-1003. https://doi.org/10.1097/01.ccm.0000119422.93413.08
  55. Wardell S, Wall A, Bryce R, Gjevre JA, Laframboise K, Reid JK. The association between obesity and outcomes in critically ill patients. Can Respir J. 2015;22(1):23-30.  https://doi.org/10.1155/2015/938930
  56. Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG, May AK. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt). 2009;10(2):137-142.  https://doi.org/10.1089/sur.2008.028
  57. Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22.  https://doi.org/10.1186/s12958-018-0336-z
  58. Li J, Daly E, Campioli E, Wabitsch M, Papadopoulos V. De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem. 2014;289(2):747-764.  https://doi.org/10.1074/jbc.M113.534172
  59. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics. 2002;110(4):e43.  https://doi.org/10.1542/peds.110.4.e43
  60. Zhao H, Zhou L, Shangguan AJ, Bulun SE. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol. 2016;57(1):19-33.  https://doi.org/10.1530/JME-15-0310
  61. Jain A, Polotsky AJ, Rochester D, Berga SL, Loucks T, Zeitlian G, Gibbs K, Polotsky HN, Feng S, Isaac B, Santoro N. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab. 2007;92(7):2468-73.  https://doi.org/10.1210/jc.2006-2274
  62. Purcell SH, Moley KH. The impact of obesity on egg quality. J Assist Reprod Genet. 2011;28(6):517-524.  https://doi.org/10.1007/s10815-011-9592-y
  63. Robker RL, Akison LK, Bennett BD, Thrupp PN, Chura LR, Russell DL, Lane M, Norman RJ. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. J Clin Endocrinol Metab. 2009;94(5):1533-1540. https://doi.org/10.1210/jc.2008-2648
  64. Ledoux S, Campos DB, Lopes FL, Dobias-Goff M, Palin MF, Murphy BD. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology. 2006;147(11):5178-5186. https://doi.org/10.1210/en.2006-0679
  65. Metwally M, Tuckerman EM, Laird SM, Ledger WL, Li TC. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod Biomed Online. 2007;14(3):328-334.  https://doi.org/10.1016/s1472-6483(10)60875-9
  66. Ruebel ML, Cotter M, Sims CR, Moutos DM, Badger TM, Cleves MA, Shankar K, Andres A. Obesity Modulates Inflammation and Lipid Metabolism Oocyte Gene Expression: A Single-Cell Transcriptome Perspective. J Clin Endocrinol Metab. 2017;102(6):2029-2038. https://doi.org/10.1210/jc.2016-3524
  67. Bellver J, Cruz F, Martínez MC, Ferro J, Ramírez JF, Pellicer A, Garrido N. Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy. Fertil Steril. 2011;96(4):931-933.  https://doi.org/10.1016/j.fertnstert.2011.07.003
  68. Fedorcsák P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 200419(11):2523-5258. https://doi.org/10.1093/humrep/deh485
  69. Glueck CJ, Streicher P, Wang P. Treatment of polycystic ovary syndrome with insulin-lowering agents. Expert Opin Pharmacother. 2002;3(8):1177-1189. https://doi.org/10.1517/14656566.3.8.1177
  70. Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(6):338-351.  https://doi.org/10.1038/nrendo.2016.222
  71. Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, Pacenza N, Stewart Usher J, Bergadá I, Campo SM. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology. 2013;1(1):3-16.  https://doi.org/10.1111/j.2047-2927.2012.00008.x
  72. Ramaswamy S, Weinbauer GF. Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone. Spermatogenesis. 2015;4(2):e996025. https://doi.org/10.1080/21565562.2014.996025
  73. Tsatsanis C, Dermitzaki E, Avgoustinaki P, Malliaraki N, Mytaras V, Margioris A. The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis. Hormones. 2015;14(4):549-562.  https://doi.org/10.14310/horm.2002.1649
  74. Garolla A, Torino M, Miola P, Caretta N, Pizzol D, Menegazzo M, Bertoldo A, Foresta C. Twenty-four-hour monitoring of scrotal temperature in obese men and men with a varicocele as a mirror of spermatogenic function. Hum Reprod. 2015;30(5):1006-1013. https://doi.org/10.1093/humrep/dev057
  75. Chen Q, Yan W, Duan E. Epigenetic inheritance of acquired traits through sperm RNAs and sperm RNA modifications. Nature Reviews Genetics. 2016; 17(12):733-743.  https://doi.org/10.1038/nrg.2016.106
  76. Du Plessis SS, Cabler S, McAlister DA, Sabanegh E, Agarwal A. The effect of obesity on sperm disorders and male infertility. Nature Reviews Urology. 2010;7(3):153-161.  https://doi.org/10.1038/nrurol.2010.6
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.